Aurora Cannabis ACB
NASDAQ ACB
$3.94 +0.13 (+3.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aurora Cannabis (ACB) Change in Accured Expenses (2017 - 2018)

Aurora Cannabis (ACB) posted quarterly Change in Accured Expenses of $3.6 million for Q4 2018, down 20.46% year-over-year from $4.5 million in Q4 2017, and down 79.47% quarter-over-quarter from $17.4 million in Q3 2018.

Aurora Cannabis (ACB) Change in Accured Expenses (2017 - 2018) Analysis & Trends

Aurora Cannabis (ACB) has reported Change in Accured Expenses for 2 consecutive years, with $3.6 million the latest figure, recorded in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 82.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 142.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -219.00 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -4.00 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -8.50 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Aurora Cannabis 243.01 Mn 170.70 Mn 25.75 Mn 687,501.94

Historic Data

Download Data
DateValue
Dec 31, 2018 3.56 Mn
Dec 31, 2018 3.56 Mn
Sep 30, 2018 17.35 Mn
Sep 30, 2018 17.35 Mn
Dec 31, 2017 4.48 Mn
Dec 31, 2017 4.48 Mn
Sep 30, 2017 -686,566.87
Sep 30, 2017 -686,566.87